Neuroprotection in Patients Undergoing Aortic Valve Replacement

Protocol: 
NCT02389894
Phase: 
Post Approval

Neuroprotection in Patients Undergoing Aortic Valve Replacement

To evaluate the efficacy and safety of embolic protection devices to reduce ischemic brain injury in patients undergoing surgical aortic valve replacement (AVR).

Are you Eligible? (Inclusion Criteria)

Patients over age 65 with aortic stenosis who will be undergoing aortic valve replacement.

  • Age ≥ 65 years
  • Planned and scheduled surgical aortic valve replacement via a full or minimal-access sternotomy (using central aortic perfusion cannulae) for calcific aortic stenosis with a legally marketed valve

Specialty Area(s)

Trial Location

NewYork-Presbyterian/Columbia University Medical Center
Department of Surgery
New York, NY 10032
United States